No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs376884588 |
chr1:155063207-155063208 |
Weak transcription Enhancers
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs559801013 |
chr1:155063210-155063211 |
Weak transcription Enhancers
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs148113725 |
chr1:155063240-155063241 |
Weak transcription Enhancers
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs551795056 |
chr1:155063244-155063245 |
Weak transcription Enhancers
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs371277548 |
chr1:155063246-155063247 |
Weak transcription Enhancers
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs531262187 |
chr1:155063304-155063305 |
Weak transcription Enhancers
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs186495675 |
chr1:155063337-155063338 |
Weak transcription Enhancers
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs141942581 |
chr1:155063371-155063372 |
Weak transcription Enhancers
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs375360766 |
chr1:155063377-155063378 |
Weak transcription Enhancers
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs150677096 |
chr1:155063391-155063392 |
Weak transcription Enhancers
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs374594189 |
chr1:155063405-155063406 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs191382535 |
chr1:155063409-155063410 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs113057340 |
chr1:155063413-155063414 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs565775862 |
chr1:155063458-155063459 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs373997476 |
chr1:155063554-155063555 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs539148985 |
chr1:155063635-155063636 |
Bivalent Enhancer Enhancers Active TSS Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs557377289 |
chr1:155063643-155063644 |
Bivalent Enhancer Enhancers Active TSS Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs376017418 |
chr1:155063680-155063681 |
Bivalent Enhancer Enhancers Active TSS Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs549643156 |
chr1:155063755-155063756 |
Bivalent Enhancer Enhancers Active TSS Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs543346346 |
chr1:155063784-155063785 |
Bivalent Enhancer Enhancers Active TSS Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs555263900 |
chr1:155063796-155063797 |
Bivalent Enhancer Enhancers Active TSS Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs370021515 |
chr1:155063813-155063814 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs569820709 |
chr1:155063926-155063927 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs541232512 |
chr1:155063930-155063931 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs180872761 |
chr1:155063961-155063962 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs578085613 |
chr1:155063996-155063997 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs142274118 |
chr1:155064094-155064095 |
Bivalent Enhancer Enhancers Active TSS Genic enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs563710921 |
chr1:155064145-155064146 |
Bivalent Enhancer Enhancers Active TSS Genic enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs146399535 |
chr1:155064149-155064150 |
Bivalent Enhancer Enhancers Active TSS Genic enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs549367020 |
chr1:155064158-155064159 |
Bivalent Enhancer Enhancers Active TSS Genic enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs139058440 |
chr1:155064248-155064249 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs528737313 |
chr1:155064299-155064300 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs202208864 |
chr1:155064319-155064320 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs547210965 |
chr1:155064344-155064345 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs571744376 |
chr1:155064374-155064375 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs539547799 |
chr1:155064382-155064383 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs368502058 |
chr1:155064390-155064391 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs551045582 |
chr1:155064460-155064461 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs373523529 |
chr1:155064505-155064506 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs184920110 |
chr1:155064507-155064508 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs374693884 |
chr1:155064561-155064562 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs536652385 |
chr1:155064570-155064571 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs562077254 |
chr1:155064582-155064583 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs371574291 |
chr1:155064584-155064585 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs554903058 |
chr1:155064590-155064591 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs573919634 |
chr1:155064615-155064616 |
Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Flanking Active TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs534611749 |
chr1:155064645-155064646 |
Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Flanking Active TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs553163442 |
chr1:155064686-155064687 |
Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Flanking Active TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs190960368 |
chr1:155064690-155064691 |
Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Flanking Active TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs545192171 |
chr1:155064708-155064709 |
Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Flanking Active TSS
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|